Recombinant P-selectin glycoprotein ligand-immunoglobulin, a P-selectin antagonist, as an adjunct to thrombolysis in acute myocardial infarction. The P-Selectin Antagonist Limiting Myonecrosis (PSALM) trial.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  American Heart Journal

• Publication date

  2006-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.AHJ.2006.04.020PMID 16824841
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Potential of Monoclonal Antibodies to Reduce Reperfusion Injury in Myocardial Infarction

  2012cited by this paper
• Jonckheere Tests for Ordered Alternatives

  2004cited by this paper
• Evaluation of cardioprotective effects of recombinant soluble P-selectin glycoprotein ligand-immunoglobulin in myocardial ischemia-reperfusion injury by real-time myocardial contrast echocardiography.

  2004cited by this paper
• The adhesion molecule P-selectin and cardiovascular disease.

  2003cited by this paper
• Efficacy of a novel P-selectin antagonist, rPSGL-Ig for reperfusion therapy in acute myocardial infarction: The RAPSODY trial

  2003cited by this paper
• Recombinant Soluble P-Selectin Glycoprotein Ligand-Ig (rPSGL-Ig) Attenuates Infarct Size and Myeloperoxidase Activity in a Canine Model of Ischemia-Reperfusion

  2002cited by this paper
• Cardiac phantom measurement validating the methodology for a cardiac multi-centre trial with positron emission tomography

  2002cited by this paper
• The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study.

  2002cited by this paper
• Therapeutic Potential of Monoclonal Antibodies in Myocardial Reperfusion Injury

  2002cited by this paper
• Double-Blind, Randomized Trial of an Anti-CD18 Antibody in Conjunction With Recombinant Tissue Plasminogen Activator for Acute Myocardial Infarction: Limitation of Myocardial Infarction Following Thrombolysis in Acute Myocardial Infarction (LIMIT AMI) Study

  2001cited by this paper
• The coronary no-reflow phenomenon: a review of mechanisms and therapies.

  2001cited by this paper
• Evaluation of the safety of recombinant P-selectin glycoprotein ligand-immunoglobulin G fusion protein in experimental models of localized and systemic infection.

  2001cited by this paper
• Pharmacokinetics, pharmacodynamics, allometry, and dose selection of rPSGL-Ig for phase I trial.

  2000cited by this paper
• The Biology of P-Selectin Glycoprotein Ligand-1: Its Role as a Selectin Counterreceptor in Leukocyte-Endothelial and Leukocyte-Platelet Interaction

  1999cited by this paper
• Continuous ST-segment monitoring associated with infarct size and left ventricular function in the GUSTO-I trial.

  1999cited by this paper
• Recombinant soluble P-selectin glycoprotein ligand-1 protects against myocardial ischemic reperfusion injury in cats.

  1999cited by this paper
• Recombinant soluble form of PSGL-1 accelerates thrombolysis and prevents reocclusion in a porcine model.

  1999cited by this paper
• Reduction of recurrent ischemia with abciximab during continuous ECG-ischemia monitoring in patients with unstable angina refractory to standard treatment (CAPTURE).

  1998cited by this paper
• [Hibernating myocardium and the 'no reflow' phenomenon: a study of absolute regional myocardial perfusion and glucose metabolism using positron emission tomography in chronic and acute heart disorders].

  1997cited by this paper
• TIMI frame count: a quantitative method of assessing coronary artery flow.

  1996cited by this paper
• Impaired myocardial tissue perfusion early after successful thrombolysis. Impact on myocardial flow, metabolism, and function at late follow-up.

  1995cited by this paper
• P-selectin and ICAM-1-dependent adherence reactions: role in the genesis of postischemic no-reflow.

  1994cited by this paper
• Continuously updated 12-lead ST-segment recovery analysis for myocardial infarct artery patency assessment and its correlation with multiple simultaneous early angiographic observations.

  1993cited by this paper
• Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils

  1991cited by this paper
• Deleterious Effects of Oxygen Radicals in Ischemia/Reperfusion Resolved and Unresolved Issues

  1989cited by this paper
• Granulocytes cause reperfusion ventricular dysfunction after 15-minute ischemia in the dog.

  1987cited by this paper
• Myocardial consequences of reperfusion.

  1987cited by this paper
• The thrombolysis in myocardial infarction (TIMI) trial.

  1985cited by this paper

• Rod‐shaped Polymerized Salicylic Acid Particles Modulate Neutrophil Transendothelial Migration in Acute Inflammation

  2025cites this paper
• Potential new cancer biomarkers revealed by quantum chemistry associated with bioinformatics in the study of selectin polymorphisms

  2024cites this paper
• Targeting the P-selectin/PSGL-1 pathway: discovery of disease-modifying therapeutics for disorders of thromboinflammation

  2024cites this paper
• Myocardial Ischemia–Reperfusion Injury: Unraveling Pathophysiology, Clinical Manifestations, and Emerging Prevention Strategies

  2024cites this paper
• Cargo-free particles divert neutrophil-platelet aggregates to reduce thromboinflammation

  2023cites this paper
• Reperfusion injury in acute ischemic stroke: Tackling the irony of revascularization.

  2023cites this paper
• Platelet–Neutrophil Crosstalk in Thrombosis

  2023cites this paper
• Aberrant protein glycosylation: Implications on diagnosis and Immunotherapy.

  2023cites this paper
• P‐ and E‐ selectin in venous thrombosis and non‐venous pathologies

  2022cites this paper
• lncRNA260 siRNA Accelerates M2 Macrophage Polarization and Alleviates Oxidative Stress via Inhibiting IL28RA Gene Alternative Splicing

  2022cites this paper
• LncRNA260 siRNA promotes M2 macrophage polarization by reducing IL28RA alternative splicing

  2022cites this paper
• Platelet-Neutrophil Interactions and Thrombo-inflammatory Complications in Type 2 Diabetes Mellitus

  2022cites this paper
• A PSGL-1 Glycomimetic Reduces Thrombus Burden Without Affecting Hemostasis.

  2021cites this paper
• Brothers in arms: platelets and neutrophils in ischemic stroke

  2021cites this paper
• Glycans and Glycan-Binding Proteins as Regulators and Potential Targets in Leukocyte Recruitment

  2021cites this paper
• Targeted pharmacotherapy for ischemia reperfusion injury in acute myocardial infarction

  2020cites this paper
• Anti-Inflammatory Treatment

  2018cites this paper
• P-Selectin Activated Platelet Monocyte Aggregates and Microvascular Dysfunction in patients with stable angina and non-ST elevation acute coronary syndrome undergoing PCI Authors

  2017cites this paper
• Platelet–neutrophil interactions as drivers of inflammatory and thrombotic disease

  2017cites this paper
• Targeting P‐selectin glycoprotein ligand‐1/P‐selectin interactions as a novel therapy for metabolic syndrome

  2017cites this paper
• Mathematical Modeling of Ischemia–Reperfusion Injury and Postconditioning Therapy

  2017cites this paper
• Mitochondrial Transplantation in Myocardial Ischemia and Reperfusion Injury.

  2017cites this paper
• Targeting neuroinflammation in the treatment and prevention of Alzheimer's disease

  2017cites this paper
• Advances in treatment strategies for ischemia reperfusion injury

  2016cites this paper
• The role of platelets in the recruitment of leukocytes during vascular disease

  2015cites this paper
• Proteasome Inhibitors : a novel therapy that blunt hyperglycemia-induced cardiac contractile dysfunction

  2015cites this paper
• Selectins: initiators of leucocyte adhesion and signalling at the vascular wall.

  2015cites this paper
• Stromal derived factor 1α: A chemokine that delivers a two-pronged defence of the myocardium

  2014cites this paper
• Clinical perspectives on reperfusion injury in acute myocardial infarction.

  2014cites this paper
• Cardioprotection for percutaneous coronary intervention--reperfusion quality as well as quantity.

  2014cites this paper
• Investigation of the effect of nitrite in the management and treatment of myocardial infarction

  2014cites this paper
• Novel adjunctive treatments of myocardial infarction.

  2014cites this paper
• Genetic and epigenetic basis of myocardial ischemia and reperfusion injury: Protection by dietary antioxidants and chromatin-modifying compounds

  2013cites this paper
• Selectins and their ligands as potential immunotherapeutic targets in neurological diseases.

  2013cites this paper
• A Thought Experiment in Contemporary Drug Development: Informed Bench‐to‐Bedside Strategies

  2013cites this paper
• Do we know enough about the immune pathogenesis of acute coronary syndromes to improve clinical practice?

  2012cites this paper
• Effect and Role of Post-conditioning During Coronary Angioplasty in Patients Affected by ST-Elevation Acute Myocardial Infarction

  2012cites this paper
• Novel treatment strategies

  2012cites this paper
• rPSGL‐Ig for Improvement of Early Liver Allograft Function: A Double‐Blind, Placebo‐Controlled, Single‐Center Phase II Study †

  2011cites this paper
• Inflammation and Immunity as Targets for Drug Therapy in Acute Coronary Syndrome

  2011cites this paper
• YSPSL (rPSGL‐Ig) for improvement of early renal allograft function: a double‐blind, placebo‐controlled, multi‐center Phase IIa study 1,2,3

  2011cites this paper
• Remote Ischemic Conditioning: A Clinical Trial’s Update

  2011cites this paper
• Enhancing myocardial salvage and regeneration as adjuncts to reperfusion therapy: unresolved issues after myocardial infarction.

  2010cites this paper
• Surprising up‐regulation of P‐selectin glycoprotein ligand‐1 (PSGL‐1) in endotoxin‐induced uveitis

  2009cites this paper
• Significant association between neutrophil aggregation in aspirated thrombus and myocardial damage in patients with ST-segment elevation acute myocardial infarction.

  2009cites this paper
• Cardiogenic Shock - Developments and Treatment Strategies

  2009cites this paper
• PS3, a semisynthetic beta-1,3-glucan sulfate, diminishes contact hypersensitivity responses through inhibition of L- and P-selectin functions.

  2009cites this paper
• [New antiplatelet drugs].

  2008cites this paper
• Targeting adhesion molecules in cardiovascular disorders.

  2008cites this paper
• In vivo imaging of endothelial injury in choriocapillaris during endotoxin‐induced uveitis

  2008cites this paper
• P-selectin

  2007cites this paper
• Macrophage &bgr;3 Integrin Suppresses Hyperlipidemia-Induced Inflammation by Modulating TNF&agr; Expression

  2007cites this paper
• Macrophage beta3 integrin suppresses hyperlipidemia-induced inflammation by modulating TNFalpha expression.

  2007cites this paper
• P- and E-selectin

  2007cites this paper
• Promises and limitations of targeting adhesion molecules for therapy

  2007cites this paper
• Periprocedural soluble P- and E-selectin levels fail as predictors of clinical restenosis in patients treated with elective coronary stenting.

  2007cites this paper